Despite major advances in the diagnosis and treatment of human lymphomas, the clinical behavior for many patients with a particular subtype of lymphoma remains unpredictable. Since host immunological mechanisms play an important role in lymphoma biology, a greater understanding of tumor host relationships in vivo should help in determining which tumor cell and host cell features are most important in predicting clinical outcome. This project will address three major aspects of the tumor host interaction in vivo: (1) the type and number of effector cells in lymphoma subgroups, (2) the numbers of tumor cells and proliferating cells in lymphoma subgroups, (3) the degree of expression of the common lymphoma-associated proto-oncogene product BCL-2 and of the multidrug resistance marker """"""""P-glycoprotein"""""""" in lymphoma subgroups. Studies of sequential biopsies from follicular lymphoma patients may provide insights in tumor progression/transformation. Ongoing studies will rely on frozen section immunohistochemical staining but increasingly will utilize antibodies reactive with fixation-resistant epitopes. Recently developed monoclonal antibodies against cytotoxic cells, memory cells, homing-associated molecules, and PCNA/Cyclin will be utilized. Gene rearrangement studies will also be performed in particular lymphoma subgroups. Quantitation of immunostained cells both in frozen and paraffin sections will employ video densitometry/image analysis. Methods will be developed for studying lymphokines and their receptors in lymphoma cells and host cells. Increased usage of dual label tissue section immunohistochemical methods will allow precise identification of lymphoma cells vs host cell expression of the various biological markers. Correlations with clinical behavior remain the major focus of this work. The identification of clinically important immunological parameters may aid physicians in the selection of a particular treatment modality, provide the rationale for delay of treatment and may prove useful in devising experimental treatment strategies. Long-term goals are to devise a more reproducible, clinically predictive classification of lymphomas. Such an in vivo evaluation of tumor host relationships should provide valuable insights in lymphoma immunobiology.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA033119-07A1
Application #
3171077
Study Section
Experimental Immunology Study Section (EI)
Project Start
1984-01-01
Project End
1994-07-31
Budget Start
1991-08-01
Budget End
1992-07-31
Support Year
7
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Matolcsy, A; Warnke, R A; Knowles, D M (1997) Somatic mutations of the translocated bcl-2 gene are associated with morphologic transformation of follicular lymphoma to diffuse large-cell lymphoma. Ann Oncol 8 Suppl 2:119-22
Matolcsy, A; Casali, P; Warnke, R A et al. (1996) Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood 88:3937-44
Gelb, A B; van de Rijn, M; Warnke, R A et al. (1996) Pregnancy-associated lymphomas. A clinicopathologic study. Cancer 78:304-10
Soslow, R A; Davis, R E; Warnke, R A et al. (1996) True histiocytic lymphoma following therapy for lymphoblastic neoplasms. Blood 87:5207-12
Hoppe, R T; Medeiros, L J; Warnke, R A et al. (1995) CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol 32:448-53
LeBrun, D P; Ngan, B Y; Weiss, L M et al. (1994) The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma. Blood 83:223-30
Gelb, A B; van de Rijn, M; Regula Jr, D P et al. (1994) Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol 25:953-60
Parsonnet, J; Hansen, S; Rodriguez, L et al. (1994) Helicobacter pylori infection and gastric lymphoma. N Engl J Med 330:1267-71
Gelb, A B; Dorfman, R F; Warnke, R A (1993) Coexistence of nodular lymphocyte predominance Hodgkin's disease and Hodgkin's disease of the usual type. Am J Surg Pathol 17:364-74
Gelb, A B; Smoller, B R; Warnke, R A et al. (1993) Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA). Am J Pathol 142:1556-64

Showing the most recent 10 out of 31 publications